Cargando…
Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into an unprecedented global pandemic. Nucleoside analogs, such as Remdesivir and Favipiravir, can serve as the first-line broad-spectrum antiviral drugs by targeting the viral polymerases. However, the underl...
Autores principales: | Peng, Qi, Peng, Ruchao, Yuan, Bin, Wang, Min, Zhao, Jingru, Fu, Lifeng, Qi, Jianxun, Shi, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834001/ https://www.ncbi.nlm.nih.gov/pubmed/33521757 http://dx.doi.org/10.1016/j.xinn.2021.100080 |
Ejemplares similares
-
Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2
por: Peng, Qi, et al.
Publicado: (2020) -
Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021) -
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir
por: Bai, Yu, et al.
Publicado: (2021) -
Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir
por: Polyakov, I. V., et al.
Publicado: (2021) -
Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)